Logo image of PSTV

PLUS THERAPEUTICS INC (PSTV) Stock Fundamental Analysis

NASDAQ:PSTV - US72941H5090 - Common Stock

0.456 USD
-0.03 (-6.9%)
Last: 8/29/2025, 8:00:01 PM
0.466 USD
+0.01 (+2.19%)
After Hours: 8/29/2025, 8:00:01 PM
Fundamental Rating

2

Overall PSTV gets a fundamental rating of 2 out of 10. We evaluated PSTV against 545 industry peers in the Biotechnology industry. The financial health of PSTV is average, but there are quite some concerns on its profitability. PSTV is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year PSTV has reported negative net income.
In the past year PSTV has reported a negative cash flow from operations.
In the past 5 years PSTV always reported negative net income.
PSTV had a negative operating cash flow in each of the past 5 years.
PSTV Yearly Net Income VS EBIT VS OCF VS FCFPSTV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M -20M -25M

1.2 Ratios

The Return On Assets of PSTV (-183.84%) is worse than 89.34% of its industry peers.
Looking at the Return On Equity, with a value of -627.13%, PSTV is doing worse than 79.78% of the companies in the same industry.
Industry RankSector Rank
ROA -183.84%
ROE -627.13%
ROIC N/A
ROA(3y)-132.52%
ROA(5y)-105.31%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PSTV Yearly ROA, ROE, ROICPSTV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for PSTV so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PSTV Yearly Profit, Operating, Gross MarginsPSTV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K

More info and screens

4

2. Health

2.1 Basic Checks

PSTV does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for PSTV has been increased compared to 1 year ago.
The number of shares outstanding for PSTV has been increased compared to 5 years ago.
PSTV has a worse debt/assets ratio than last year.
PSTV Yearly Shares OutstandingPSTV Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
PSTV Yearly Total Debt VS Total AssetsPSTV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

PSTV has an Altman-Z score of -68.03. This is a bad value and indicates that PSTV is not financially healthy and even has some risk of bankruptcy.
PSTV has a Altman-Z score of -68.03. This is amonst the worse of the industry: PSTV underperforms 94.30% of its industry peers.
There is no outstanding debt for PSTV. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -68.03
ROIC/WACCN/A
WACC9.34%
PSTV Yearly LT Debt VS Equity VS FCFPSTV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M

2.3 Liquidity

A Current Ratio of 1.26 indicates that PSTV should not have too much problems paying its short term obligations.
With a Current ratio value of 1.26, PSTV is not doing good in the industry: 84.19% of the companies in the same industry are doing better.
PSTV has a Quick Ratio of 1.26. This is a normal value and indicates that PSTV is financially healthy and should not expect problems in meeting its short term obligations.
PSTV has a worse Quick ratio (1.26) than 83.27% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 1.26
PSTV Yearly Current Assets VS Current LiabilitesPSTV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 35.56% over the past year.
PSTV shows a decrease in Revenue. In the last year, the revenue decreased by -3.49%.
The Revenue has been decreasing by -3.61% on average over the past years.
EPS 1Y (TTM)35.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%103.57%
Revenue 1Y (TTM)-3.49%
Revenue growth 3YN/A
Revenue growth 5Y-3.61%
Sales Q2Q%8.68%

3.2 Future

Based on estimates for the next years, PSTV will show a very strong growth in Earnings Per Share. The EPS will grow by 30.02% on average per year.
Based on estimates for the next years, PSTV will show a very strong growth in Revenue. The Revenue will grow by 100.84% on average per year.
EPS Next Y69.13%
EPS Next 2Y35.48%
EPS Next 3Y24.9%
EPS Next 5Y30.02%
Revenue Next Year8.56%
Revenue Next 2Y8.23%
Revenue Next 3Y60.98%
Revenue Next 5Y100.84%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
PSTV Yearly Revenue VS EstimatesPSTV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M
PSTV Yearly EPS VS EstimatesPSTV Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 -500K -1M -1.5M -2M -2.5M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

PSTV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year PSTV is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PSTV Price Earnings VS Forward Price EarningsPSTV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PSTV Per share dataPSTV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1 -1.5 -2

4.3 Compensation for Growth

A more expensive valuation may be justified as PSTV's earnings are expected to grow with 24.90% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.48%
EPS Next 3Y24.9%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for PSTV!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PLUS THERAPEUTICS INC

NASDAQ:PSTV (8/29/2025, 8:00:01 PM)

After market: 0.466 +0.01 (+2.19%)

0.456

-0.03 (-6.9%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)08-14 2025-08-14/amc
Earnings (Next)11-12 2025-11-12/amc
Inst Owners2.11%
Inst Owner Change23.41%
Ins Owners0.16%
Ins Owner Change42.28%
Market Cap45.26M
Analysts80
Price Target9.01 (1875.88%)
Short Float %3.13%
Short Ratio0.05
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-286.82%
Min EPS beat(2)-695.44%
Max EPS beat(2)121.79%
EPS beat(4)3
Avg EPS beat(4)-133.71%
Min EPS beat(4)-695.44%
Max EPS beat(4)121.79%
EPS beat(8)6
Avg EPS beat(8)-58.75%
EPS beat(12)8
Avg EPS beat(12)-40.03%
EPS beat(16)9
Avg EPS beat(16)-31.45%
Revenue beat(2)0
Avg Revenue beat(2)-19.16%
Min Revenue beat(2)-30.01%
Max Revenue beat(2)-8.31%
Revenue beat(4)1
Avg Revenue beat(4)-1.68%
Min Revenue beat(4)-30.01%
Max Revenue beat(4)37.49%
Revenue beat(8)2
Avg Revenue beat(8)-2.41%
Revenue beat(12)3
Avg Revenue beat(12)-6.7%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.64%
PT rev (3m)-8.23%
EPS NQ rev (1m)76%
EPS NQ rev (3m)94.12%
EPS NY rev (1m)16.88%
EPS NY rev (3m)22.97%
Revenue NQ rev (1m)-10.57%
Revenue NQ rev (3m)40%
Revenue NY rev (1m)-4.9%
Revenue NY rev (3m)-9.1%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 8.51
P/FCF N/A
P/OCF N/A
P/B 14.92
P/tB 20.02
EV/EBITDA N/A
EPS(TTM)-2.03
EYN/A
EPS(NY)-0.36
Fwd EYN/A
FCF(TTM)-0.17
FCFYN/A
OCF(TTM)-0.17
OCFYN/A
SpS0.05
BVpS0.03
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -183.84%
ROE -627.13%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-132.52%
ROA(5y)-105.31%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 5.64%
Cap/Sales 0.66%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.26
Quick Ratio 1.26
Altman-Z -68.03
F-Score4
WACC9.34%
ROIC/WACCN/A
Cap/Depr(3y)67.77%
Cap/Depr(5y)74.15%
Cap/Sales(3y)82.31%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)35.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%103.57%
EPS Next Y69.13%
EPS Next 2Y35.48%
EPS Next 3Y24.9%
EPS Next 5Y30.02%
Revenue 1Y (TTM)-3.49%
Revenue growth 3YN/A
Revenue growth 5Y-3.61%
Sales Q2Q%8.68%
Revenue Next Year8.56%
Revenue Next 2Y8.23%
Revenue Next 3Y60.98%
Revenue Next 5Y100.84%
EBIT growth 1Y9.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year20.17%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-11.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-12.26%
OCF growth 3YN/A
OCF growth 5YN/A